Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clostridium butyricum Reduces Obesity in a Butyrate-Independent Way

16 May 2023

Abstract excerpt

Accumulating evidence from recent studies links the gut microbiota to obesity, and microbiome therapy has been examined as a treatment. Clostridium butyricum (C. butyricum), an intestinal symbiont, protects the host from a range of diseases. Studies have shown a negative correlation between the relative abundance of C. butyricum and a predisposition for obesity. However, the physiological function and material...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37317266
DOI: 10.3390/microorganisms11051292

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clostridium butyricum Reduces Obesity in a Butyrate-Independent WayPMID 37317266Read ↗

Butyrate-producing human gut symbiont, Clostridium butyricum , and its role in health and diseaseSemantic proximity Read ↗

Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4Semantic proximity Read ↗

Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese MiceSemantic proximity Read ↗

Abundance of the species Clostridium butyricum in the gut microbiota contributes to differences in obesity phenotype in outbred Sprague-Dawley CD rats.Semantic proximity Read ↗

Effect of Clostridium butyricum on Gastrointestinal InfectionsSemantic proximity Read ↗

Direct and Indirect Evidence of Effects of Bacteroides spp. on Obesity and InflammationSemantic proximity Read ↗

Cross-feeding-based rational design of a probiotic combination of Bacterides xylanisolvens and Clostridium butyricum therapy for metabolic diseasesSemantic proximity Read ↗

Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studiesSemantic proximity Read ↗

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the ResearchSemantic proximity Read ↗

A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 ReceptorSemantic proximity Read ↗

Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated RatsSemantic proximity Read ↗

Therapeutic Potential of Butyrate for Treatment of Type 2 DiabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.